0ADQ Stock Chart & Stats
$122.55
$0.00(0.00%)
At close: 4:00 PM EDT
$122.55
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$122.55 - $122.55
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$12.84B
Enterprise Value$17.04K
Total Cash (Recent Filing)$455.38M
Total Debt (Recent Filing)$2.94B
Price to Earnings (P/E)11.0
Beta1.09
Next Earnings
Oct 28, 2026EPS Estimate
4.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)15.22
Shares Outstanding76,849,450
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.51
Price to Book (P/B)1.89
Price to Sales (P/S)1.89
P/FCF Ratio9.02
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$194.33Price Target Upside58.57% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)15.73
Revenue Forecast (FY)$6.40B
Bulls Say, Bears Say
Bulls Say
Steady Premium And Earnings GrowthRecurring premium growth across the insurance portfolio supports a durable revenue base, while the accompanying EPS outlook indicates operating leverage and continued earnings expansion. Health and United American growth provide additional momentum beyond the mature life business.
Strong Cash GenerationConsistent conversion of earnings into cash gives Globe Life flexibility to fund policy operations, invest its insurance float, repurchase shares, and pay dividends. The strong TTM improvement reinforces the company’s capacity to support capital returns without relying solely on accounting profits.
Conservative Investment And Capital PositionA high-quality investment portfolio and robust risk-based capital ratio strengthen the insurer’s ability to meet policyholder obligations and withstand claims variability. This financial foundation also supports ongoing premium growth and shareholder distributions while limiting credit-related earnings pressure.
Bears Say
Health Underwriting Margin PressureHigher health obligations and a lower underwriting margin indicate that claims experience is currently absorbing more premium revenue. If adjustments involving Medicare Supplement, cancer claims, or other health benefits persist, they could constrain profitability and make earnings less predictable.
EVRI Startup Losses Weigh On MarginsThe EVRI launch is consuming underwriting capacity before reaching sufficient scale, creating a direct drag on United American’s health margins. Continued losses or slower-than-expected scale-up could dilute the benefits of strong health premium growth and pressure consolidated earnings.
Distribution Disruption And Agent AttritionGlobe Life is facing pressure in two important acquisition channels: digital search disruption is weakening DTC sales, and lower AIL agent counts are limiting life-sales productivity. Management expects adaptation and improvement, but recruiting and channel-transition execution remain material risks to growth.
Globe Life News
0ADQ FAQ
What was Globe Life’s price range in the past 12 months?
Globe Life lowest share price was $122.55 and its highest was $122.55 in the past 12 months.
What is Globe Life’s market cap?
Globe Life’s market cap is $12.84B.
When is Globe Life’s upcoming earnings report date?
Globe Life’s upcoming earnings report date is Oct 28, 2026 which is in 28 days.
How were Globe Life’s earnings last quarter?
Globe Life released its earnings results on Jul 22, 2026. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.673 by -$0.063.
Is Globe Life overvalued?
According to Wall Street analysts Globe Life’s price is currently Undervalued.
Does Globe Life pay dividends?
Globe Life does not currently pay dividends.
What is Globe Life’s EPS estimate?
Globe Life’s EPS estimate is 4.92.
How many shares outstanding does Globe Life have?
Globe Life has 76,849,450 shares outstanding.
What happened to Globe Life’s price movement after its last earnings report?
Globe Life reported an EPS of $3.61 in its last earnings report, missing expectations of $3.673. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Globe Life?
Currently, no hedge funds are holding shares in GB:0ADQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Globe Life Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$194.33 (58.57% Upside)
$194.33 (58.57% Upside)
Blogger Sentiment
Neutral
GB:0ADQ Sentiment 80%
Sector Average 60%
Sector Average 60%
Insider Transactions
Sold Shares
Worth $31.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.24%
12-Months-Change
Fundamentals
Return on Equity
0.68%
Trailing 12-Months
Asset Growth
5.88%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Globe Life
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
0ADQ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple strong positives — double-digit GAAP and operating EPS growth, premium growth (especially in health and United American), improving investment yields and conservative portfolio positioning, an expanded share repurchase program, and upward guidance aided by expected assumption-update benefits. Counterbalancing these are execution and margin pressures: DTC sales disruption from AI-driven changes in search, a YoY decline in AIL agent count (though with sequential improvement), elevated health claims and higher health obligation ratios in Q2, and a near-term drag from the EVRI startup. Investment unrealized losses are interest-rate driven and manageable per management. On balance the company emphasized resilient operations, conservative investments, returning capital to shareholders, and clear plans to address distribution and AI-related digital changes.View all GB:0ADQ earnings summaries0ADQ Revenue Breakdown
56.44% Life
24.31% Health
0.00% Annuity
19.65% Investment
<0.01% Corporate & Other
-0.42% Realized gains (losses)
0ADQ Stock 12 Month Forecast
Average Price Target
$194.33
▲(58.57% Upside)